Sub Banner Image

Novo Taps New CEO, Cuts Guidance as Wegovy Sales Slump

Markets

·

July 29, 2025

·

Bloomberg

Novo Nordisk A/S named Maziar Mike Doustdar as chief executive officer after slumping weight-loss drug sales led to a profit warning that wiped out $93 billion off its market value. Damian Garde reports on Bloomberg Television.

More from

Bloomberg

More

Markets

Articles

Trending News

Enjoy premium content in your inbox.

You're in! Check your email to learn more.
Oops! Something went wrong while submitting the form.